Cargando…
Free heme exacerbates colonic injury induced by anti-cancer therapy
Gastrointestinal inflammation and bleeding are commonly induced by cancer radiotherapy and chemotherapy but mechanisms are unclear. We demonstrated an increased number of infiltrating heme oxygenase-1 positive (HO-1+) macrophages (Mø, CD68+) and the levels of hemopexin (Hx) in human colonic biopsies...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277564/ https://www.ncbi.nlm.nih.gov/pubmed/37342339 http://dx.doi.org/10.3389/fimmu.2023.1184105 |
_version_ | 1785060310807216128 |
---|---|
author | Seika, Philippa Janikova, Monika Asokan, Sahana Janovicova, Lubica Csizmadia, Eva O’Connell, Mckenzie Robson, Simon C. Glickman, Jonathan Wegiel, Barbara |
author_facet | Seika, Philippa Janikova, Monika Asokan, Sahana Janovicova, Lubica Csizmadia, Eva O’Connell, Mckenzie Robson, Simon C. Glickman, Jonathan Wegiel, Barbara |
author_sort | Seika, Philippa |
collection | PubMed |
description | Gastrointestinal inflammation and bleeding are commonly induced by cancer radiotherapy and chemotherapy but mechanisms are unclear. We demonstrated an increased number of infiltrating heme oxygenase-1 positive (HO-1+) macrophages (Mø, CD68+) and the levels of hemopexin (Hx) in human colonic biopsies from patients treated with radiation or chemoradiation versus non-irradiated controls or in the ischemic intestine compared to matched normal tissues. The presence of rectal bleeding in these patients was also correlated with higher HO-1+ cell infiltration. To functionally assess the role of free heme released in the gut, we employed myeloid-specific HO-1 knockout (LysM-Cre : Hmox1(flfl) ), hemopexin knockout (Hx(-/-) ) and control mice. Using LysM-Cre : Hmox1(flfl) conditional knockout (KO) mice, we showed that a deficiency of HO-1 in myeloid cells led to high levels of DNA damage and proliferation in colonic epithelial cells in response to phenylhydrazine (PHZ)-induced hemolysis. We found higher levels of free heme in plasma, epithelial DNA damage, inflammation, and low epithelial cell proliferation in Hx(-/-) mice after PHZ treatment compared to wild-type mice. Colonic damage was partially attenuated by recombinant Hx administration. Deficiency in Hx or Hmox1 did not alter the response to doxorubicin. Interestingly, the lack of Hx augmented abdominal radiation-mediated hemolysis and DNA damage in the colon. Mechanistically, we found an altered growth of human colonic epithelial cells (HCoEpiC) treated with heme, corresponding to an increase in Hmox1 mRNA levels and heme:G-quadruplex complexes-regulated genes such as c-MYC, CCNF, and HDAC6. Heme-treated HCoEpiC cells exhibited growth advantage in the absence or presence of doxorubicin, in contrast to poor survival of heme-stimulated RAW247.6 Mø. In summary, our data indicate that accumulation of heme in the colon following hemolysis and/or exposure to genotoxic stress amplifies DNA damage, abnormal proliferation of epithelial cells, and inflammation as a potential etiology for gastrointestinal syndrome (GIS). |
format | Online Article Text |
id | pubmed-10277564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102775642023-06-20 Free heme exacerbates colonic injury induced by anti-cancer therapy Seika, Philippa Janikova, Monika Asokan, Sahana Janovicova, Lubica Csizmadia, Eva O’Connell, Mckenzie Robson, Simon C. Glickman, Jonathan Wegiel, Barbara Front Immunol Immunology Gastrointestinal inflammation and bleeding are commonly induced by cancer radiotherapy and chemotherapy but mechanisms are unclear. We demonstrated an increased number of infiltrating heme oxygenase-1 positive (HO-1+) macrophages (Mø, CD68+) and the levels of hemopexin (Hx) in human colonic biopsies from patients treated with radiation or chemoradiation versus non-irradiated controls or in the ischemic intestine compared to matched normal tissues. The presence of rectal bleeding in these patients was also correlated with higher HO-1+ cell infiltration. To functionally assess the role of free heme released in the gut, we employed myeloid-specific HO-1 knockout (LysM-Cre : Hmox1(flfl) ), hemopexin knockout (Hx(-/-) ) and control mice. Using LysM-Cre : Hmox1(flfl) conditional knockout (KO) mice, we showed that a deficiency of HO-1 in myeloid cells led to high levels of DNA damage and proliferation in colonic epithelial cells in response to phenylhydrazine (PHZ)-induced hemolysis. We found higher levels of free heme in plasma, epithelial DNA damage, inflammation, and low epithelial cell proliferation in Hx(-/-) mice after PHZ treatment compared to wild-type mice. Colonic damage was partially attenuated by recombinant Hx administration. Deficiency in Hx or Hmox1 did not alter the response to doxorubicin. Interestingly, the lack of Hx augmented abdominal radiation-mediated hemolysis and DNA damage in the colon. Mechanistically, we found an altered growth of human colonic epithelial cells (HCoEpiC) treated with heme, corresponding to an increase in Hmox1 mRNA levels and heme:G-quadruplex complexes-regulated genes such as c-MYC, CCNF, and HDAC6. Heme-treated HCoEpiC cells exhibited growth advantage in the absence or presence of doxorubicin, in contrast to poor survival of heme-stimulated RAW247.6 Mø. In summary, our data indicate that accumulation of heme in the colon following hemolysis and/or exposure to genotoxic stress amplifies DNA damage, abnormal proliferation of epithelial cells, and inflammation as a potential etiology for gastrointestinal syndrome (GIS). Frontiers Media S.A. 2023-06-05 /pmc/articles/PMC10277564/ /pubmed/37342339 http://dx.doi.org/10.3389/fimmu.2023.1184105 Text en Copyright © 2023 Seika, Janikova, Asokan, Janovicova, Csizmadia, O’Connell, Robson, Glickman and Wegiel https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Seika, Philippa Janikova, Monika Asokan, Sahana Janovicova, Lubica Csizmadia, Eva O’Connell, Mckenzie Robson, Simon C. Glickman, Jonathan Wegiel, Barbara Free heme exacerbates colonic injury induced by anti-cancer therapy |
title | Free heme exacerbates colonic injury induced by anti-cancer therapy |
title_full | Free heme exacerbates colonic injury induced by anti-cancer therapy |
title_fullStr | Free heme exacerbates colonic injury induced by anti-cancer therapy |
title_full_unstemmed | Free heme exacerbates colonic injury induced by anti-cancer therapy |
title_short | Free heme exacerbates colonic injury induced by anti-cancer therapy |
title_sort | free heme exacerbates colonic injury induced by anti-cancer therapy |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277564/ https://www.ncbi.nlm.nih.gov/pubmed/37342339 http://dx.doi.org/10.3389/fimmu.2023.1184105 |
work_keys_str_mv | AT seikaphilippa freehemeexacerbatescolonicinjuryinducedbyanticancertherapy AT janikovamonika freehemeexacerbatescolonicinjuryinducedbyanticancertherapy AT asokansahana freehemeexacerbatescolonicinjuryinducedbyanticancertherapy AT janovicovalubica freehemeexacerbatescolonicinjuryinducedbyanticancertherapy AT csizmadiaeva freehemeexacerbatescolonicinjuryinducedbyanticancertherapy AT oconnellmckenzie freehemeexacerbatescolonicinjuryinducedbyanticancertherapy AT robsonsimonc freehemeexacerbatescolonicinjuryinducedbyanticancertherapy AT glickmanjonathan freehemeexacerbatescolonicinjuryinducedbyanticancertherapy AT wegielbarbara freehemeexacerbatescolonicinjuryinducedbyanticancertherapy |